Lansoprazole treatment of patients with chronic idiopathic laryngitis: a placebo-controlled trial
dc.contributor.author | El-Serag, Hashem B. | en_US |
dc.contributor.author | Lee, Patty | en_US |
dc.contributor.author | Buchner, Anna | en_US |
dc.contributor.author | Inadomi, John M. | en_US |
dc.contributor.author | Gavin, Michael | en_US |
dc.contributor.author | McCarthy, Denis M. | en_US |
dc.date.accessioned | 2010-06-01T18:14:25Z | |
dc.date.available | 2010-06-01T18:14:25Z | |
dc.date.issued | 2001-04 | en_US |
dc.identifier.citation | El-Serag, Hashem B . ; Lee, Patty; Buchner, Anna; Inadomi, John M . ; Gavin, Michael; McCarthy, Denis M . (2001). "Lansoprazole treatment of patients with chronic idiopathic laryngitis: a placebo-controlled trial." The American Journal of Gastroenterology 96(4): 979-983. <http://hdl.handle.net/2027.42/71451> | en_US |
dc.identifier.issn | 0002-9270 | en_US |
dc.identifier.issn | 1572-0241 | en_US |
dc.identifier.uri | https://hdl.handle.net/2027.42/71451 | |
dc.identifier.uri | http://www.ncbi.nlm.nih.gov/sites/entrez?cmd=retrieve&db=pubmed&list_uids=11316215&dopt=citation | en_US |
dc.description.abstract | Previous uncontrolled studies suggested a therapeutic benefit for treating gastroesophageal reflux disease (GERD) among patients with laryngitis. The present study is the first randomized, placebo-controlled, double-blind study of gastric acid suppression among patients with laryngitis in the United States. Methods : Patients diagnosed with idiopathic chronic laryngitis were randomized to receive either lansoprazole 30 mg p.o. b.i.d. or a matching placebo for 3 months. Before randomization, all patients underwent upper endoscopy, dual probe ambulatory 24-h esophageal pH-metry, and laryngoscopy, as well as completing a symptom questionnaire for GERD and laryngitis. The primary outcome of treatment was the complete resolution of laryngeal symptoms. Results : A total of 22 patients with symptoms and signs of chronic laryngitis were enrolled, 20 of whom completed the study. At baseline, there were no significant differences between the two groups with regards to GERD symptoms, erosive esophagitis, proximal and distal esophageal pH-metry, or laryngeal signs and symptoms. In an intention-to-treat analysis, six patients in the lansoprazole group (50%) and only one patient (10%) in the placebo group achieved a complete symptomatic response, p =; 0.04. Apart from receiving lansoprazole, there were no significant differences between responders and nonresponders in any of baseline esophageal or laryngeal signs and symptoms. Conclusions : Empirical treatment with lansoprazole is efficacious in relieving symptoms of laryngitis compared to placebo. Such treatment can be considered as a first-line option in managing patients with idiopathic chronic laryngitis. | en_US |
dc.format.extent | 62878 bytes | |
dc.format.extent | 3109 bytes | |
dc.format.mimetype | application/pdf | |
dc.format.mimetype | text/plain | |
dc.publisher | Blackwell Publishing Ltd | en_US |
dc.rights | 2001 by Am. Coll. of Gastroenterology | en_US |
dc.title | Lansoprazole treatment of patients with chronic idiopathic laryngitis: a placebo-controlled trial | en_US |
dc.type | Article | en_US |
dc.subject.hlbsecondlevel | Internal Medicine and Specialties | en_US |
dc.subject.hlbtoplevel | Health Sciences | en_US |
dc.description.peerreviewed | Peer Reviewed | en_US |
dc.contributor.affiliationum | Divisions of Gastroenterology and Health Services Research, Ann Arbor VA Medical Center and University of Michigan, Ann Arbor, Michigan, USA | en_US |
dc.contributor.affiliationother | Divisions of Gastroenterology and Health Services Research, Houston VA Medical Center and Baylor College of Medicine, Houston, Texas | en_US |
dc.contributor.affiliationother | Otolaryngology Department and Division of Gastroenterology, Albuquerque VA Medical Center and University of New Mexico, Albuquerque, New Mexico | en_US |
dc.identifier.pmid | 11316215 | en_US |
dc.description.bitstreamurl | http://deepblue.lib.umich.edu/bitstream/2027.42/71451/1/j.1572-0241.2001.03681.x.pdf | |
dc.identifier.doi | 10.1111/j.1572-0241.2001.03681.x | en_US |
dc.identifier.source | The American Journal of Gastroenterology | en_US |
dc.identifier.citedreference | El-Serag H.B., Sonnenberg A.. Comorbid occurrence of laryngeal or pulmonary disease with esophagitis in United States Veterans. Gastroenterology 1997; 113: 755 – 760. | en_US |
dc.identifier.citedreference | Koufman J.A.. The otolaryngologic manifestations of gastroesophageal reflux disease (GERD): A clinical investigation of 225 patients using ambulatory 24-hour pH monitoring and an experimental investigation of the role of acid and pepsin in the development of laryngeal injury. Laryngoscope 1991; 101: 1 – 65. | en_US |
dc.identifier.citedreference | Richter J.E.. Extraesophageal presentations of gastroesophageal reflux disease. Semin Gastrointest Dis 1997; 8: 75 – 89. | en_US |
dc.identifier.citedreference | Young J.L., Shaw G.Y., Searl J.P., et al. Laryngeal manifestation of gastroesophageal reflux disease: Endoscopic appearance and management. Gastrointest Endosc 1995; 43: 225 – 230. | en_US |
dc.identifier.citedreference | Wiener G.J., Koufman J.A., Wu W.C., et al. Chronic hoarseness secondary to gastroesophageal reflux disease: Documentation with 24-H ambulatory pH monitoring. Am J Gastroenterol 1989; 84: 1503 – 1508. | en_US |
dc.identifier.citedreference | Wilson J.A., White A., Haacke N.P., et al. Gastroesophageal reflux disease and posterior laryngitis. Ann Otol Rhinol Laryngol 1989; 98: 405 – 410. | en_US |
dc.identifier.citedreference | Kamel P.L., Hanson D., Kharilas P.J.. Omeprazole for the treatment of posterior laryngitis. Am J Med 1994; 96: 321 – 326. | en_US |
dc.identifier.citedreference | Kamel P.L., Hanson D.G., Kharilas P.J.. Outcomes of antireflux therapy in the treatment of chronic laryngitis. Ann Otol Rhinol Laryngol 1995; 104: 550 – 555. | en_US |
dc.identifier.citedreference | Waring J.P., Lacayo L., Hunter J., et al. Chronic cough and hoarseness in patients with gastroesophageal reflux disease. Dig Dis Sci 1995; 40: 1093 – 1097. | en_US |
dc.identifier.citedreference | Wo J.M., Grist W.J., Gussack G., et al. Empiric trial of high-dose omeprazole in patients with posterior laryngitis: A prospective study. Am J Gastroenterol 1997; 92: 2160 – 2165. | en_US |
dc.identifier.citedreference | Japerson D., Weber R., Draf W., et al. Omeprazole for the treatment of reflux associated chronic laryngitis. J Gastroenterol 1996; 31: 765 – 767. | en_US |
dc.identifier.citedreference | Armstrong D., Bennet J.R., Blum A.L., et al. The endoscopic assessment of esophagitis: A progress report on observer agreement. Gastroenterology 1996; 111: 85 – 92. | en_US |
dc.identifier.citedreference | Havas T., Huang S., Levy M., et al. Posterior pharyngolaryngitis – double-blind randomized placebo-controlled trial of proton pump inhibitor therapy. Aust J Otolaryng 1999; 3: 243 – 246. | en_US |
dc.identifier.citedreference | Vaezi M.F., Schroeder P.L., Richter J.E.. Reproducibility of proximal pH parameters in 24-hour ambulatory esophageal pH monitoring. Am J Gastroenterol 1997; 92: 825 – 829. | en_US |
dc.identifier.citedreference | Smit C.F., Tan J., Devriese P.P., et al. Ambulatory pH measurements at the upper esophageal sphincter. Laryngoscope 1998; 108: 299 – 302. | en_US |
dc.identifier.citedreference | Dobhan R., Castell D.O.. Normal, and abnormal proximal esophageal acid exposure: Results of ambulatory dual-probe pH monitoring. Am J Gastroenterol 1993; 88: 25 – 29. | en_US |
dc.identifier.citedreference | Klauser A.G., Schindlbeckm N.E., Muller-Lissner S.A.. Symptoms in gastro-oesophageal reflux disease. Lancet 1990; 335 ( 8683 ): 205 – 8. | en_US |
dc.identifier.citedreference | Euler A.R., Byrne W.J.. Twenty four hour esophageal intraluminal pH probe testing: A comparative analysis. Gastroenterology 1981; 80: 957 – 961. | en_US |
dc.identifier.citedreference | Jamieson J.R., Sten H.J., DeMeester T.R., et al. Ambulatory 24-hour esophageal pH monitoring: Normal values, optimal thresholds, specificity, sensitivity, and reproducibility. Am J Gastroenterol 1992; 87: 1102 – 1111. | en_US |
dc.identifier.citedreference | Richter J.E., Hicks D.M.. Unresolved issues in gastroesophageal reflux-related ear, nose, and throat problems. Am J Gastroenterol 1997; 92: 2143 – 2144. | en_US |
dc.identifier.citedreference | Schenk B.E., Kuipers E.J., Klinkenberg-Knol E.C., et al. Omeprazole as a diagnostic tool in gastroesophageal reflux disease. Am J Gastroenterol 1997; 92: 1997 – 2000. | en_US |
dc.identifier.citedreference | Fass R., Ofman J.J., Gralnek I.M., et al. Clinical and economic assessment of the omeprazole test in patients with symptoms suggestive of gastroesophageal reflux disease. Arch Intern Med 1999; 159: 2161 – 2168. | en_US |
dc.identifier.citedreference | Fass R., Fennerty M.B., Ofman J.J., et al. The clinical and economic value of a short course of omeprazole in patients with noncardiac chest pain. Gastroenterology 1998; 115: 42 – 49. | en_US |
dc.identifier.citedreference | Ours T.M., Kavuru M.S., Schilz R.J., et al. A prospective evaluation of esophageal testing and a double-blind, randomized study of omeprazole in a diagnostic and therapeutic algorithm for chronic cough. Am J Gastroenterol 1999; 94: 3131 – 3138. | en_US |
dc.owningcollname | Interdisciplinary and Peer-Reviewed |
Files in this item
Remediation of Harmful Language
The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.
Accessibility
If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.